Vijayakumar S - Search Results

1

Glucose-Lowering Therapies and Heart Failure in Type 2 Diabetes Mellitus: Mechanistic Links, Clinical Data, and Future Directions.

Vijayakumar S, Vaduganathan M, Butler J. Vijayakumar S, et al. Circulation. 2018 Mar 6;137(10):1060-1073. doi: 10.1161/CIRCULATIONAHA.117.032099. Circulation. 2018. PMID: 29506996 Free PMC article. Review.

2

Exploring heart failure events in contemporary cardiovascular outcomes trials in type 2 diabetes mellitus.

Vijayakumar S, Vaduganathan M, Butler J. Vijayakumar S, et al. Expert Rev Cardiovasc Ther. 2018 Feb;16(2):123-131. doi: 10.1080/14779072.2018.1423962. Epub 2018 Jan 9. Expert Rev Cardiovasc Ther. 2018. PMID: 29298108 Review.

3

Multiple Avenues of Modulating the Nitric Oxide Pathway in Heart Failure Clinical Trials.

Singh P, Vijayakumar S, Kalogeroupoulos A, Butler J. Singh P, et al. Among authors: vijayakumar s. Curr Heart Fail Rep. 2018 Apr;15(2):44-52. doi: 10.1007/s11897-018-0383-y. Curr Heart Fail Rep. 2018. PMID: 29476326 Review.

4

Need to revisit heart failure treatment guidelines for hyperkalaemia management during the use of mineralocorticoid receptor antagonists.

Butler J, Vijayakumar S, Pitt B. Butler J, et al. Among authors: vijayakumar s. Eur J Heart Fail. 2018 Sep;20(9):1247-1251. doi: 10.1002/ejhf.1217. Epub 2018 Jun 8. Eur J Heart Fail. 2018. PMID: 29882618 Free PMC article. Review. No abstract available.

5

Revisiting hyperkalaemia guidelines: rebuttal.

Butler J, Vijayakumar S, Pitt B. Butler J, et al. Among authors: vijayakumar s. Eur J Heart Fail. 2018 Sep;20(9):1255. doi: 10.1002/ejhf.1249. Eur J Heart Fail. 2018. PMID: 30182493 Free article. No abstract available.

6

New treatments for hyperkalaemia: clinical use in cardiology.

Vijayakumar S, Butler J, Anker SD. Vijayakumar S, et al. Eur Heart J Suppl. 2019 Feb;21(Suppl A):A41-A47. doi: 10.1093/eurheartj/suy031. Epub 2019 Feb 26. Eur Heart J Suppl. 2019. PMID: 30837804 Free PMC article.

7

Barriers to guideline mandated renin-angiotensin inhibitor use: focus on hyperkalaemia.

Vijayakumar S, Butler J, Bakris GL. Vijayakumar S, et al. Eur Heart J Suppl. 2019 Feb;21(Suppl A):A20-A27. doi: 10.1093/eurheartj/suy030. Epub 2019 Feb 26. Eur Heart J Suppl. 2019. PMID: 30837801 Free PMC article.

8

The Cardiovascular Manifestations of COVID-19.

Louis DW, Saad M, Vijayakumar S, Ilyas S, Kokkirala A, Aronow HD. Louis DW, et al. Among authors: vijayakumar s. Cardiol Clin. 2022 Aug;40(3):277-285. doi: 10.1016/j.ccl.2022.03.001. Epub 2022 Mar 23. Cardiol Clin. 2022. PMID: 35851451 Free PMC article. Review.

9

A 57-Year-Old Woman on Rituximab Presenting With Fever and Lethargy.

Cafone J, Vijayakumar S, Ahmad S. Cafone J, et al. Among authors: vijayakumar s. Chest. 2018 May;153(5):e97-e99. doi: 10.1016/j.chest.2017.11.047. Chest. 2018. PMID: 29731054 No abstract available.

10

Long-term Cardiovascular Manifestations and Complications of COVID-19: Spectrum and Approach to Diagnosis and Management.

Khetpal V, Berkowitz J, Vijayakumar S, Choudhary G, Mukand JA, Rudolph JL, Wu WC, Erqou S. Khetpal V, et al. Among authors: vijayakumar s. R I Med J (2013). 2022 Sep 1;105(7):16-22. R I Med J (2013). 2022. PMID: 35930485 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

712 results

Search Page